Cue Biopharma, Inc. (DUS:1UC0) Financings

Cue Biopharma, Inc.

Financings

RaiseDate
Private placement of common stock and pre-funded warrants
Announced: about US$50M · US$33.21 a share
Buyers: Cormorant Asset Management; Columbia Threadneedle Investments
Use of proceeds: Further fund clinical development and general corporate purposes
Jul 10, 2026
Private placement of pre-funded warrants and accompanying common stock warrants
Announced: about US$30M · US$11 a share · Warrants at US$11 · Newbridge Securities Corporation
Dealers: Newbridge Securities Corporation (lead)
Use of proceeds: Advance the clinical pipeline, including acquiring and developing Ascendant-221, working capital and general corporate purposes
Apr 30, 2026
Public offering of shares of common stock (or pre-funded warrants) and accompanying common stock warrants
Announced: about US$10M · US$0.28 a share · Warrants at US$0.3 for 60 months · H.C. Wainwright & Co. +1
Dealers: H.C. Wainwright & Co. (lead), Newbridge Securities Corporation
Dec 19, 2025
Public offering of common stock and accompanying common stock warrants, pre-funded warrants
Closed: US$20M raised · US$0.79 a share · Warrants at US$0.79 for 60 months · Oppenheimer & Co. Inc. +1
Dealers: Oppenheimer & Co. Inc. (lead), Newbridge Securities Corporation
Aug 12, 2025

Read by 6ix AI from the company's releases